Mucin Biopolymers As Broad-Spectrum Antiviral Agents

Mucus is a porous biopolymer matrix that coats all wet epithelia in the human body and serves as the first line of defense against many pathogenic bacteria and viruses. However, under certain conditions viruses are able to penetrate this infection barrier, which compromises the protective function o...

Full description

Bibliographic Details
Main Authors: Lieleg, Oliver, Lieleg, Corinna, Bloom, Jesse, Buck, Christopher B., Ribbeck, Katharina
Other Authors: Massachusetts Institute of Technology. Department of Biological Engineering
Format: Article
Language:en_US
Published: American Chemical Society (ACS) 2014
Online Access:http://hdl.handle.net/1721.1/89156
https://orcid.org/0000-0001-8260-338X
_version_ 1826207229174349824
author Lieleg, Oliver
Lieleg, Corinna
Bloom, Jesse
Buck, Christopher B.
Ribbeck, Katharina
author2 Massachusetts Institute of Technology. Department of Biological Engineering
author_facet Massachusetts Institute of Technology. Department of Biological Engineering
Lieleg, Oliver
Lieleg, Corinna
Bloom, Jesse
Buck, Christopher B.
Ribbeck, Katharina
author_sort Lieleg, Oliver
collection MIT
description Mucus is a porous biopolymer matrix that coats all wet epithelia in the human body and serves as the first line of defense against many pathogenic bacteria and viruses. However, under certain conditions viruses are able to penetrate this infection barrier, which compromises the protective function of native mucus. Here, we find that isolated porcine gastric mucin polymers, key structural components of native mucus, can protect an underlying cell layer from infection by small viruses such as human papillomavirus (HPV), Merkel cell polyomavirus (MCV), or a strain of influenza A virus. Single particle analysis of virus mobility inside the mucin barrier reveals that this shielding effect is in part based on a retardation of virus diffusion inside the biopolymer matrix. Our findings suggest that purified mucins may be used as a broad-range antiviral supplement to personal hygiene products, baby formula or lubricants to support our immune system.
first_indexed 2024-09-23T13:46:03Z
format Article
id mit-1721.1/89156
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T13:46:03Z
publishDate 2014
publisher American Chemical Society (ACS)
record_format dspace
spelling mit-1721.1/891562022-09-28T16:00:43Z Mucin Biopolymers As Broad-Spectrum Antiviral Agents Lieleg, Oliver Lieleg, Corinna Bloom, Jesse Buck, Christopher B. Ribbeck, Katharina Massachusetts Institute of Technology. Department of Biological Engineering Ribbeck, Katharina Lieleg, Oliver Lieleg, Corinna Mucus is a porous biopolymer matrix that coats all wet epithelia in the human body and serves as the first line of defense against many pathogenic bacteria and viruses. However, under certain conditions viruses are able to penetrate this infection barrier, which compromises the protective function of native mucus. Here, we find that isolated porcine gastric mucin polymers, key structural components of native mucus, can protect an underlying cell layer from infection by small viruses such as human papillomavirus (HPV), Merkel cell polyomavirus (MCV), or a strain of influenza A virus. Single particle analysis of virus mobility inside the mucin barrier reveals that this shielding effect is in part based on a retardation of virus diffusion inside the biopolymer matrix. Our findings suggest that purified mucins may be used as a broad-range antiviral supplement to personal hygiene products, baby formula or lubricants to support our immune system. National Institutes of Health (U.S.) (grant P30-ES002109) National Institutes of Health (U.S.) (grant P50-GM068763) German Academic Exchange Service (Postdoctoral fellowship) 2014-09-03T18:09:37Z 2014-09-03T18:09:37Z 2012-06 2012-03 Article http://purl.org/eprint/type/JournalArticle 1525-7797 1526-4602 http://hdl.handle.net/1721.1/89156 Lieleg, Oliver, Corinna Lieleg, Jesse Bloom, Christopher B. Buck, and Katharina Ribbeck. “Mucin Biopolymers As Broad-Spectrum Antiviral Agents.” Biomacromolecules 13, no. 6 (June 11, 2012): 1724–1732. https://orcid.org/0000-0001-8260-338X en_US http://dx.doi.org/10.1021/bm3001292 Biomacromolecules Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf American Chemical Society (ACS) PMC
spellingShingle Lieleg, Oliver
Lieleg, Corinna
Bloom, Jesse
Buck, Christopher B.
Ribbeck, Katharina
Mucin Biopolymers As Broad-Spectrum Antiviral Agents
title Mucin Biopolymers As Broad-Spectrum Antiviral Agents
title_full Mucin Biopolymers As Broad-Spectrum Antiviral Agents
title_fullStr Mucin Biopolymers As Broad-Spectrum Antiviral Agents
title_full_unstemmed Mucin Biopolymers As Broad-Spectrum Antiviral Agents
title_short Mucin Biopolymers As Broad-Spectrum Antiviral Agents
title_sort mucin biopolymers as broad spectrum antiviral agents
url http://hdl.handle.net/1721.1/89156
https://orcid.org/0000-0001-8260-338X
work_keys_str_mv AT lielegoliver mucinbiopolymersasbroadspectrumantiviralagents
AT lielegcorinna mucinbiopolymersasbroadspectrumantiviralagents
AT bloomjesse mucinbiopolymersasbroadspectrumantiviralagents
AT buckchristopherb mucinbiopolymersasbroadspectrumantiviralagents
AT ribbeckkatharina mucinbiopolymersasbroadspectrumantiviralagents